Training program for foot muscles in patients with Multiple Sclerosis
Effects of Intrinsic Foot Muscles Training in Improving Stability in Multiple Sclerosis Patients
This study tests if an 8-week program of foot muscle exercises can help people with Multiple Sclerosis improve their balance and mobility.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 34 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Salamanca Academic / other |
| Locations | 1 site (Valladolid) |
| Trial ID | NCT06665607 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an 8-week intrinsic muscle training program aimed at improving stability in patients diagnosed with Multiple Sclerosis. Participants will engage in specific exercises designed to strengthen foot muscles, which may help enhance their overall balance and mobility. The study focuses on individuals with moderate neurological disability, as measured by the Expanded Disability Status Scale. The outcomes will be assessed to determine the impact of this training on stability and muscle function.
Who should consider this trial
Good fit: Ideal candidates are patients with moderate neurological disability due to Multiple Sclerosis, scoring between 3.0 and 6.0 on the EDSS.
Not a fit: Patients with cognitive disturbances, visual or vestibular disorders, recent medication changes, acute relapses, or orthopedic issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this training program could significantly improve balance and mobility for patients with Multiple Sclerosis.
How similar studies have performed: While similar approaches have been explored, this specific training program's efficacy in Multiple Sclerosis is novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with moderate neurological disability as scored by the Expanded Disability Status Scale (EDSS), ranging from 3.0 to 6.0 Exclusion Criteria: * Cognitive disturbances that could affect the performance of any of the tests or questionnaires included in the study * Diagnosis of visual or vestibular disorders that could affect patient stability * Change in Multiple Sclerosis-specific medication in the 2 months prior to the start of the study * Acute relapse in the 2 months prior to the start of the study * Traumatologic or orthopaedic disorders that could negatively affect balance.
Where this trial is running
Valladolid
- Universidad de Valladolid — Valladolid, Spain (Recruiting)
Study contacts
- Study coordinator: Daniel García García, PhD
- Email: daniel.ggarcia@uva.es
- Phone: 620712485
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.